Product NDC: | 44087-8822 |
Proprietary Name: | Rebif |
Non Proprietary Name: | interferon beta-1a |
Active Ingredient(s): | & nbsp; interferon beta-1a |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44087-8822 |
Labeler Name: | EMD Serono, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103780 |
Marketing Category: | BLA |
Start Marketing Date: | 20041217 |
Package NDC: | 44087-8822-1 |
Package Description: | 1 KIT in 1 CARTON (44087-8822-1) * .2 mL in 1 SYRINGE, GLASS * .5 mL in 1 SYRINGE, GLASS |
NDC Code | 44087-8822-1 |
Proprietary Name | Rebif |
Package Description | 1 KIT in 1 CARTON (44087-8822-1) * .2 mL in 1 SYRINGE, GLASS * .5 mL in 1 SYRINGE, GLASS |
Product NDC | 44087-8822 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | interferon beta-1a |
Dosage Form Name | KIT |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20041217 |
Marketing Category Name | BLA |
Labeler Name | EMD Serono, Inc. |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |